NCT06629636
Investigate the Efficacy of Using NMN to Improve Embryo Development Capacity.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 18 words Show 5 more changesShow less
- Trial completed
- Primary completion date changed from estimate of Sep 30, 2025 to Dec 30, 2025
- Study completion date changed from estimate of Dec 31, 2026 to Dec 31, 2025
- Site details revised
- Publications: details revised at 7 of 7 entries
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Embryo development rate
Timeframe: Up to 8 weeks post-intervention
Changes in metabolic status
Timeframe: Up to 8 weeks post-intervention
Clinical pregnancy rate
Timeframe: Up to 12months post-intervention
Secondary (7)
Live Birth rates
Endocrine hormones including AMH
Average egg retrieval capacity per person
Additional in vitro fertilization - outcome indicators
Chemical pregnancy rate
Show 2 moreShow less
Pregnancy complication
Abortion rate
Arms and interventions
NMN interventionActive comparator
NMN capsules (total of 900mg/day) for 8 weeks
Placebo interventionPlacebo comparator
NMN-free placebo capsules for 8 weeks
Dietary supplements: NMN capsule
Other: Placebo
Sites
1 site in 1 country
- IVF Namba Clinic, Sankaky Medical CorporationOsaka, Osaka, Japan